1. Home
  2. AXIL vs INMB Comparison

AXIL vs INMB Comparison

Compare AXIL & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXIL Brands Inc.

AXIL

AXIL Brands Inc.

N/A

Current Price

$5.75

Market Cap

45.4M

ML Signal

N/A

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

N/A

Current Price

$1.35

Market Cap

34.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXIL
INMB
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.4M
34.3M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
AXIL
INMB
Price
$5.75
$1.35
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.87
AVG Volume (30 Days)
8.7K
490.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$26,257,522.00
$14,000.00
Revenue This Year
N/A
$264.29
Revenue Next Year
N/A
N/A
P/E Ratio
$43.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.04
$1.16
52 Week High
$10.25
$11.64

Technical Indicators

Market Signals
Indicator
AXIL
INMB
Relative Strength Index (RSI) 44.29 45.69
Support Level $4.76 $1.21
Resistance Level $6.25 $1.71
Average True Range (ATR) 0.52 0.13
MACD -0.04 0.01
Stochastic Oscillator 26.48 55.22

Price Performance

Historical Comparison
AXIL
INMB

About AXIL AXIL Brands Inc.

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Share on Social Networks: